Abstract:Purpose: To evaluate the influence of rapamycin on endothelial-mesenchymal transition and matrix metalloproteinase (MMP) secretion by human umbilical vein endothelial cell line EA.hy926 and explore rapamycin's angiogenesis inhibition mechanism.Methods: EA.hy926 cells were cultivated in vitro. After the cells attained complete confluency, an artificial scratch was made through the monolayer with a sterile plastic 100 mu l micropipette tip. Cell morphology changes were observed. The expression of vascular endothelial (VE)-cadherin, vimentin, and Twist protein were examined by immunofluorescence. After scratching, the cells were treated with 10, 100, and 1,000 ng/ml rapamycin for durations of 24, 48, and 72 h. Cell proliferation was then assessed using methyl thiazolyl tetrazolium assay. Cell migration ability was examined, and the expression of VE-cadherin, vimentin, and the Twist transcription factor in mRNA levels was evaluated with reverse transcriptase PCR. The expression of gelatinases (MMP-2 and MMP-9) was examined using gelatin zymography.Results: After scratching, the endothelial cells were able to migrate via an endothelial-to-mesenchymal transition, which was related to Twist expression. Finally, mesenchymal cells transitioned into endothelial cells and reached cell confluency again. The growth of EA.hy926 cells was not affected by rapamycin concentrations of 10 ng/ml or 100 ng/ml during treatment periods of 1, 2, and 3 days; however, cell growth was inhibited by 1,000 ng/ml rapamycin with a three-day treatment period. Rapamycin successfully inhibited cell migration at concentrations of 10 ng/ml, 100 ng/ml, and 1,000 ng/ml for a treatment period of up to 8 h. Different concentrations of rapamycin induced the expression of VE-cadherin, inhibited vimentin and Twist expression in the endothelial cells, and inhibited endothelial cell secretion of MMP-2 and MMP-9.Conclusions: Rapamycin inhibited cell migration and extracellular matrix degradation by inhibiting endothelial-tomesenchymal transition and the endothelial cell secretion of MMP-2 and MMP-9; these may be possible mechanisms for the inhibition of angiogenesis by rapamycin.

Effects of rapamycin on number and activity of endothelial progenitor cells

MicroRNA-21 mediates the rapamycin-induced suppression of endothelial proliferation and migration.

Effects of rapamycin on proliferation,apoptosis and nitric oxide secretion of rat endothelial progenitor cells

Effects of Constant Magnetic Fields on Proliferation and Migration of Endothelial Progenitor Cells under Rapamycin Intervention: Experiment with Rats

[Effects of Angiotensin II on Peripheral Blood Endothelial Progenitor Cells].

Vascular endothelial growth factor on function of endothelial progenitor cells from peripheral blood

Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and Mtor/ P70S6K/4EBP1 Signaling.

The Effects of Rapamycin on Endothelial Cell Migration and Vascular Endothelial Growth Factor Expression

Proteasome Inhibitor MG132 Suppresses Number and Function of Endothelial Progenitor Cells: Involvement of Nitric Oxide Synthase Inhibition.

Protective Effect of Silymarin Against Rapamycin-Induced Apoptosis and Proliferation Inhibition in Endothelial Progenitor Cells.

How does autophagy activation affect the apoptosis, proliferation and cycle of endothelial progenitor cells in rats?

Rapamycin Prevents Endothelial Cell Migration by Inhibiting the Endothelial-To-Mesenchymal Transition and Matrix Metalloproteinase-2 and -9: an in Vitro Study

Rapamycin and 3-Methyladenine Regulate Apoptosis and Autophagy in Bone-Derived Endothelial Progenitor Cells

Effects of Rapamycin on the Differentiation and Function of Macrophages in Vitro

Effects of Rapamycin on Proliferation, Function and Cell-Cycle of Mouse T Lymphocytes in Vitro

Effects of rapamycin on DC-SIGN expression and biological functions in DC.

The effects of rapamycin on lens epithelial cell proliferation, migration, and matrix formation: an in vitro study.

Effect of Resveratrol on Proliferation and Differentiation of Endothelial Progenitor Cells from Peripheral Blood in Vitro

The effect of rapamycin on PC12 cells injured by oxygen and glucose deprivation

Rapamycin Inhibits Ox-Ldl-induced Inflammation in Human Endothelial Cells in Vitro by Inhibiting the Mtorc2/pkc/c-Fos Pathway

Immunomodulation of T Cell-Mediated Alloimmunity by Proximity to Endothelial Cells under the Mammalian Target of Rapamycin Blockade.